Cost-effectiveness of 13-valent pneumococcal polysaccharide conjugate vaccine in Indian adults aged ≥50 years [0.03%]
印度50岁以上成人接种13价肺炎球菌多糖结合疫苗的成本效益分析
Namrata Kulkarni,Ahuva Averin,Santosh Taur et al.
Namrata Kulkarni et al.
Objectives: Lacking national policy for adult pneumococcal vaccination, local Indian guidelines recommend 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13) followed by 23-valent pneumococcal polysaccharide v...
The potential public health impact of new immunization strategies for the prevention of RSV in children in Panama [0.03%]
巴拿马预防儿童呼吸道合胞病毒新免疫策略的潜在公共健康影响
Xavier Sáez-Llorens,Pieralessandro Lasalvia,Paola Jaramillo et al.
Xavier Sáez-Llorens et al.
Objective: New prophylaxis to reduce the burden of respiratory syncytial virus (RSV) disease are available, including a long-acting monoclonal antibody (nirsevimab) and maternal immunization with an RSV prefusion F protei...
Clinical and economic outcomes of patients with cardiorenal and metabolic diseases: a real-world analysis in a single Italian Local Health Unit [0.03%]
心血管-肾脏和代谢疾病患者的临床及经济效益结局：意大利单个卫生区的现实世界分析
Valentina Perrone,Domenica Daniela Ancona,Marco Gnesi et al.
Valentina Perrone et al.
Background: This single-center real-world analysis describes the epidemiology, demographic and clinical characteristics, mortality, and therapeutic-care management of patients grouped by the presence of seven cardiorenal ...
Exploring the psychometric properties of the fatigue severity scale: results from a systematic review and reliability meta-analysis [0.03%]
疲劳严重程度量表的测量属性：系统评价和可靠度meta分析结果
Ilaria Ruotolo,Andrea Carenza,Giovanni Sellitto et al.
Ilaria Ruotolo et al.
Introduction: Fatigue is a multifactorial phenomenon that affects individuals across several conditions. Fatigue Severity Scale (FSS) is a widely used questionnaire to measure perceived fatigue. This systematic review aim...
Healthcare resource utilization and associated costs in patients with metastatic castration-resistant prostate cancer in Greece [0.03%]
希腊转移性去势抵抗性前列腺癌患者的医疗资源利用及其相关成本
E Bournakis,A Bournakis,D V Zolota et al.
E Bournakis et al.
Background: Prostate cancer is a leading cause of cancer death among men. Metastatic castration-resistant prostate cancer (mCRPC) treatment has changed dramatically since the introduction of novel hormonal agents (NHAs); ...
Cost-effectiveness analysis of FOLFOXIRI plus bevacizumab versus mFOLFOX6 plus bevacizumab as first-line treatment of metastatic colorectal cancer [0.03%]
贝伐单抗联合FOLFOXIRI与贝伐单抗联合mFOLFOX6一线治疗转移性结直肠癌的疗效成本分析
Tong Liu,Yao Yao,Bingjie Liu et al.
Tong Liu et al.
Objectives: We first evaluated thecost-effectiveness of the FOLFOXIRI plus bevacizumab versus mFOLFOX6 plusbevacizumab as the first-line treatment of metastatic colorectal cancer fromhealthcare system perspective. ...
Economic and developmental impacts of FDA designations: a systematic review and meta-analysis [0.03%]
美国食品药品管理局指定的经济和开发影响：系统评价和meta分析
Joab Williamson,Syed Shahzad Hasan,Vijay S Gc
Joab Williamson
Introduction: U.S. FDA designations: Breakthrough Therapy (BTD), Fast Track (FTD), Orphan Drug (ODD), and Regenerative Medicine Advanced Therapy (RMAT) aim to expedite drug development, yet their combined economic and dev...
Budget impact of lecanemab for medicare beneficiaries with early Alzheimer's disease in the United States: a subgroup analysis [0.03%]
美国早期阿尔茨海默病医疗保险受益人使用乐健美单抗的预算影响：亚组分析
Vassiki Sanogo,Reem Dhayan Saud Almutairi,Vakaramoko Diaby
Vassiki Sanogo
Background: In 2024, Alzheimer's disease affected approximately 6.9 million Americans aged 65 and older. Current therapies include acetylcholinesterase inhibitors, N-methyl-D-aspartate receptor inhibitors, and monoclonal ...
Valuing prevention: lessons and recommendations from a Dutch expert committee [0.03%]
重视预防：荷兰专家委员会的经验与启示
Adriënne Rotteveel,Saskia Knies,Ardine de Wit et al.
Adriënne Rotteveel et al.
Introduction: Countries have been struggling with investments in prevention. How to obtain insight in the costs, benefits, and budgetary impacts of investments in prevention? And how to weigh investments in prevention aga...
Willingness to pay for a quality-adjusted life year (QALY) in Pakistan: implications for health policy [0.03%]
巴基斯坦的健康政策中质量调整生命年的支付意愿的影响：质量调整生命年的支付意愿分析
Faizur Rehman,Muhammad Wasay Shahid,Mehran Riaz et al.
Faizur Rehman et al.
Objectives: Allocating healthcare resources in developing countries like Pakistan is constrained by economic limitations and uneven distribution. Therefore, in this study, we aimed to investigate the Willingness to Pay (W...